PNC Financial Services Group’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

PNC Financial Services Group’s Portfolio ZIVO Stock Details ZIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-105	Closed	-$818	–	4818
2023 Q3	$818	Hold	105	–	–	﹤0.01%	4413
2023 Q2	$1.52K	Hold	105	–	–	﹤0.01%	4437
2023 Q1	$1.94K	Hold	105	–	–	﹤0.01%	4320
2022 Q4	$1.57K	Hold	105	–	–	﹤0.01%	4318
2022 Q3	$2K	Sell	105 -104	-50%	-$2.29K	﹤0.01%	4231
2022 Q2	$5K	Buy	209 +105	+101%	+$2.11K	﹤0.01%	4019
2022 Q1	$2K	Hold	104	–	–	﹤0.01%	4253
2021 Q4	$2K	Hold	104	–	–	﹤0.01%	4213
2021 Q3	$3K	Hold	104	–	–	﹤0.01%	4067
2021 Q2	$3K	Buy	+104	New	+$2.83K	﹤0.01%	4002

Other funds holding ZIVO

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

PNC Financial Services Group's ZIVO Position: Q4 2023 in Review

PNC Financial Services Group sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q4 2023, closing a stake of 105 shares — an estimated $818 sold.

PNC Financial Services Group first reported a position in ZIVO in Q2 2021 and held it in 10 quarters. The position peaked at $5K in Q2 2022. 2 funds tracked by Wall St. Rank hold ZIVO as of Q4 2023.

PNC Financial Services Group reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
PNC Financial Services Group sold 105 Zivo Bioscience, Inc. Common Stock shares in Q4 2023, an estimated $818.
PNC Financial Services Group first reported a position in Zivo Bioscience, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
PNC Financial Services Group's Zivo Bioscience, Inc. Common Stock position peaked at $5K in Q2 2022.
2 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q4 2023.

Based on PNC Financial Services Group's 13F filing for Q4 2023, filed 9 Feb 2024.